4.5 Article

Can Brain-derived Neurotrophic Factor (BDNF) Mimetics be a Way Out for Neurodegenerative Diseases?

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Chronic partial TrkB activation reduces seizures and mortality in a mouse model of Dravet syndrome

Feng Gu et al.

Summary: Dravet syndrome is a severe childhood epilepsy caused by mutations in the Scn1a gene. Early treatment with a partial BDNF TrkB receptor agonist can improve PV interneuron function, reduce seizures, and increase survival rates.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Review Biochemistry & Molecular Biology

New Frontiers in Neurodegeneration and Regeneration Associated with Brain-Derived Neurotrophic Factor and the rs6265 Single Nucleotide Polymorphism

Carlye A. Szarowicz et al.

Summary: This article provides a summary of the role of BDNF in the pathogenesis and rehabilitation of various neurodegenerative and psychiatric disorders. Low levels of BDNF are associated with disease states, and BDNF replacement therapies show promise. The BDNF pro-peptide and rs6265 expression also play important roles.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Neurosciences

Acute treatment with TrkB agonist LM22A-4 confers neuroprotection and preserves myelin integrity in a mouse model of pediatric traumatic brain injury

Jessica L. Fletcher et al.

Summary: The study found that targeting TrkB immediately after early-life TBI can reduce brain tissue damage, preserve myelin integrity, provide neuroprotection, and lead to some improved neurobehavioral outcomes.

EXPERIMENTAL NEUROLOGY (2021)

Article Biochemistry & Molecular Biology

Suggesting 7,8-dihydroxyflavone as a promising nutraceutical against CNS disorders

Rajib Paul et al.

Summary: 7,8-dihydroxyflavone (DHF) is a naturally-occurring flavone with neuroprotective properties that can combat various neurological disorders, exhibiting antioxidant and anti-inflammatory effects.

NEUROCHEMISTRY INTERNATIONAL (2021)

Article Multidisciplinary Sciences

Dimeric mimetic of BDNF loop 4 promotes survival of serum-deprived cell through TrkB-dependent apoptosis suppression

L. F. Zainullina et al.

Summary: GSB-106, a dimeric dipeptide compound, mimics certain biological functions of BDNF and displays protective properties by promoting neuronal cell survival and counteracting cell apoptosis. It also shows similarities to some known low weight peptide and non-peptide TrkB ligands.

SCIENTIFIC REPORTS (2021)

Article Biochemistry & Molecular Biology

Optimized TrkB Agonist Ameliorates Alzheimer's Disease Pathologies and Improves Cognitive Functions via Inhibiting Delta-Secretase

Chun Chen et al.

Summary: The synthetic derivative CF3CN optimized from 7,8-DHF interacts with the TrkB LRM/CC2 domain, activating TrkB neurotrophic signaling and showing potential as a preclinical candidate for treating neurodegenerative diseases, particularly Alzheimer's disease. Chronic treatment of CF3CN demonstrates therapeutic efficacy with no observable toxicity, providing promise for future clinical applications.

ACS CHEMICAL NEUROSCIENCE (2021)

Article Biochemistry & Molecular Biology

Dipeptide Mimetics of Different NGF and BDNF Loops Activate PLC-γ1

T. A. Gudasheva et al.

DOKLADY BIOCHEMISTRY AND BIOPHYSICS (2020)

Article Neurosciences

Mechanisms of neurotrophin trafficking via Trk receptors

Emily Scott-Solomon et al.

MOLECULAR AND CELLULAR NEUROSCIENCE (2018)

Review Cell Biology

BDNF: A Key Factor with Multipotent Impact on Brain Signaling and Synaptic Plasticity

Przemyslaw Kowianski et al.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2018)

Article Cell Biology

Pathology of Neurodegenerative Diseases

Brittany N. Dugger et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)

Article Chemistry, Medicinal

Mimetics of brain-derived neurotrophic factor loops 1 and 4 are active in a model of ischemic stroke in rats

Tatyana A. Gudasheva et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2016)

Review Nanoscience & Nanotechnology

Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness

Igor Khalin et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2015)

Article Medicine, Research & Experimental

PTP1B inhibition suggests a therapeutic strategy for Rett syndrome

Navasona Krishnan et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

Review Biochemistry & Molecular Biology

7,8-Dihydroxyflavone as a pro-neurotrophic treatment for neurodevelopmental disorders

X. Du et al.

NEUROCHEMISTRY INTERNATIONAL (2015)

Article Neurosciences

TDP6, a brain-derived neurotrophic factor-based trkB peptide mimetic, promotes oligodendrocyte myelination

Agnes W. Wong et al.

MOLECULAR AND CELLULAR NEUROSCIENCE (2014)

Article Biochemistry & Molecular Biology

A small peptide mimetic of brain-derived neurotrophic factor promotes peripheral myelination

Junhua Xiao et al.

JOURNAL OF NEUROCHEMISTRY (2013)

Article Medicine, Research & Experimental

Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents

Stephen M. Massa et al.

JOURNAL OF CLINICAL INVESTIGATION (2010)